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Moderate zinc restriction affects intestinal health and immune function in 
lipopolysaccharide-challenged mice 
Daniel G. Peterson , Angus G. Scrimgeour , James P. McClung , Elizabeth A. Koutsos Abstract 
Zinc (Zn) is an essential nutrient that affects immune function, especially within the digestive system, although the underlying 
mechanisms are not well understood. This study examined the effects of short term moderate Zn restriction on intestinal health and immune 
function in lipopolysaccharide (LPS) challenged mice through plasma cytokine profiling and histological evaluation of intestinal tissue 
sections. Adult male mice were fed with a Zn adequate (40 ppm) or a Zn marginal (4 ppm) diet for 4 weeks, and then a bacterial challenge 
was simulated by intraperitoneal injection of LPS (10 μg/g body weight [BW]) or saline (control). BW was recorded weekly, and feed intake 
was recorded daily over the last week. Voluntary locomotor activity was assessed 6 and 24 h after the challenge. Plasma and tissues were 
collected 0, 6 or 24 h after the challenge for analysis. Histological analysis of intestinal samples included evaluation of villi length and width, 
lamina propria (LP) width, crypt depth and intraepithelial as well as LP leukocyte numbers. Plasma was analyzed for IL 1β, IL 4, IL 6, IL 
10, IL 12p40, IL 12p70, interferon gamma and tumor necrosis factor α. Diet did not affect BW and feed intake. The LPS challenge led to 
decreased voluntary locomotor activity (Pb.05). Moderate Zn restriction led to greater leukocyte infiltration in the LP after the LPS challenge 
(Pb.05) and higher plasma IL 6 and IL 10 levels 24 h after the LPS challenge (Pb.01). Results indicate that Zn status impacts intestinal 
responses to LPS through modulation of the cytokine response and leukocyte recruitment, and this impact is evident even with short term 
(4 weeks) moderate Zn restriction.  1. Introduction	 
Zinc (Zn) is a nutritionally essential trace element that 
functions in numerous metabolic pathways. It plays a critical 
role in immune function (reviewed in Reference [1]) as
moderate Zn deficiency and severe Zn deficiency are known 
to affect immunity in human and nonhuman models [2,3]. Zn  
status includingfunctionslymphocyte numerousaffects mitogenesis, antibody synthesis and other facets of cell-
mediated immunity, which are negatively impacted by Zn 
deficiency (reviewed in Reference [4]). Humoral immunity is 
also affected by Zn deficiency, which induces B-lymphocyte 
apoptosis and reduces antibody responses (reviewed in 
Reference [5]), although Zn deficiency does not affect the 
production of IL-4, IL-6 and IL-10 [6] cytokine expression in 
either nonchallenged or immune-challenged cells and 
animals [7,8]. Zn deficiency decreases IL-2 [6,9,10] and 
interferon gamma (IFNγ; [6,7,10]) production by peripheral 
blood mononuclear cells (PBMCs) but increases tumor 
necrosis factor α (TNFα) production by endothelial cells 
[11] and innate immune cells [8,10]. Similarly, moderate Zn 
restriction increases IL-1β production by PBMCs [6,8,10] 
and IL-8 messenger RNA expression [10]. 
Zn is also implicated in diarrhea due to its effects on 
intestinal mucosal permeability [12] and the ability of dietary 
 Zn to prevent or alleviate intestinal diseases [13]. At
pharmacological levels, this effect may be due to the 
antimicrobial properties of Zn (e.g., [14]) and disruption of 
bacterial-enterocyte binding as well as subsequent bacterial 
translocation [15]. However, at physiological levels, it is 
more likely that Zn affects intestinal physiology and immune 
function through its effects on cytokine production, as 
mentioned above. 
The level of dietary Zn examined is a critical component 
of any investigation of the effect of Zn status on intestinal 
immune function and systemic immune function. Immune 
modulation by Zn has typically been studied in the context of 
frank Zn deficiency, although moderate Zn deficiency is of 
interest because this nutritional condition is difficult to 
diagnose — yet classical studies have demonstrated 
increased growth of Zn-supplemented children even from 
middle to upper socioeconomic classes in the United States 
and Canada [16,17]. This trial compared Zn adequacy with 
moderate Zn restriction in adult animals in order to assess the 
primary effects of Zn restriction in the absence of secondary 
effects such as impaired growth and decreased intake. 
Intestinal immune function is often studied in the context 
of oral administration of a pathogen or an immunogenic 
compound. However, the use of live pathogens is of concern 
due to limitations on quantification of the exact number of 
organisms and their proliferative capacity after the challenge. 
Therefore, this trial examined a non-oral challenge that 
elicited intestinal and systemic immune responses. 
The objectives of the present study were to determine the 
ability of an intraperitoneal challenge to elicit intestinal and 
systemic immune responses and to examine the effects of 
moderate Zn restriction on these intestinal responses as well 
as on systemic cytokine concentrations in adult male mice. 2. Materials and methods 
2.1. Animals and treatments 
All procedures were approved by the California Poly­
technic State University Institutional Animal Care and Use 
Committee. Male BALB/c mice (n=96, 6 weeks old, mean 
body weight (BW)=20.05 g; Harlan, Indianapolis, IN, USA) 
were housed in eight cages (n=12/cage), and each cage was 
supplied with either a Zn-adequate (40.1±4.2 ppm) or a Zn­
marginal (3.9±1.8 ppm) diet (Research Diets, New Bruns­
wick, NJ, USA) for 4 weeks. Zn content of feed was assessed 
using flame atomic absorption spectroscopy (Perkin Elmer 
2380, Perkin Elmer, Norwalk, CT, USA). Feed (∼1.0 g of 
each diet) samples were diluted eightfold with 5% nitric acid 
(trace metal grade, Fisher Scientific, Pittsburgh, PA, USA). 
Zn standards, prepared from a reference solution (Fisher 
Scientific) in 5% nitric acid, were used as internal control. 
All analyses were conducted in acid-washed glassware. 
Recovery tests were performed to confirm the accuracy of 
the abovementioned method, and the recovery of Zn was 
108±1.1% (n=5, CV=2.3%). In order to avoid environmental exposure to Zn, animals were allowed free access to 
deionized water at all times and were housed in plastic 
cages. BW was recorded weekly throughout the study, and 
feed intake was recorded daily for the last week of the study. 
After 4 weeks of the dietary treatments, half of the 
animals in each cage (n=6) were exposed to intraperitoneal 
injection of saline (0.2 ml, control) and the other half (n=6) 
were injected with lipopolysaccharide (LPS; 10 μg/g BW in 
0.2 ml) to simulate a bacterial challenge. LPS (intraper­
itoneal route) has previously been shown to induce 
monocyte adhesion and infiltration into intestinal tissues of 
mice [18]; thus, it was predicted that LPS would induce 
intestinal distress, similar to other diarrhea models. Four 
animals from each cage (two control and two LPS) were 
euthanized by CO2 asphyxiation for sample collection 0, 6 
and 24 h after the intraperitoneal challenge. 
2.2. Behavioral analysis 
Prior to sample collection, animals were assessed for 
voluntary locomotor activity by a method adapted from the 
work of Cravatt et al. [19]. Briefly, each mouse was placed in 
the center of a 78�56-cm cage marked with 7-cm2 grid lines 
on the bottom, and the number of squares traversed in 1 min 
was recorded. 
2.3. Tissue sample collection 
Immediately after euthanasia, blood was collected into 
heparinized tubes and plasma was isolated and frozen at 
−20°C for cytokine analysis. Subsequently, intestinal 
samples were isolated from animals 24 h after the challenge. 
Jejunum samples were isolated from the intestine immedi­
ately distal to the pancreatic loop. Ileum samples were 
isolated from the midpoint between the jejunum and the 
ileocecal junction. Each intestinal sample was immediately 
washed with cold saline and then rinsed with 10% formalin, 
recut to ∼2-cm sections and placed in 10% formalin jars for 
embedding and hematoxylin–eosin staining by a commercial 
laboratory (IDEXX, West Sacramento, CA, USA). 
2.4. Plasma cytokine analysis 
Plasma cytokine analysis was performed using Bio-Plex 
mouse cytokine assay panels (Bio-Rad Laboratories, Her­
cules, CA, USA) analyzed using a Luminex 100 analyzer 
(Luminex, Austin, TX, USA). Cytokines analyzed were 
IFNγ, IL-1β IL-4, IL-5, IL-6, IL-10, IL-12p40, IL-12p70 
and TNFα. 
2.5. Histological analysis of intestinal sections 
For each intestinal section (per animal), three villi were 
randomly selected to measure villus length, villus width, 
lamina propria (LP) width and crypt depth as well as to count 
leukocytes in the LP and intraepithelial regions. Using a 5� 
field, villus length was evaluated as the distance from the 
apical region to the base of the villus and villus width was 
evaluated as the distance from one side of the brush border 
Table 1 
Feed intake and BW of animals fed with a Zn-adequate (Ad-Zn) diet and 
those fed with a Zn-marginal (Lo-Zn) diet 
Lo-Zn diet Ad-Zn diet P 
Intake (g/day) 
Initial BW (g) 
Final BW (g) 
2.59±0.06 
20.34±0.33 
24.32±0.26 
2.56±0.05 
19.76±0.12 
23.65±0.23 
.52 
.12 
.07 
Intake was measured daily during Week 4, and BW was measured weekly 
across the 4-week experiment (n 4 cages/diet, 12 animals/cage). Values are 
expressed as mean±S.E.M. 
able 3 
ean plasma cytokine concentrations (pg/ml) of mice 0, 6 or 24 h after 
hallenge by intraperitoneal injection of LPS or saline after 4-week 
eatment with either an Ad-Zn or an Lo-Zn diet a 
LPS Saline S.E.M. Effect 
0 h 6 h  24 h  0 h  6 h  24 h  
-1β 
Ad-Zn 18.1 87.4 13.9 20.5 10.7 21.6 15.2 NS membrane to the other side of the brush border membrane 
[20]. Using a 10� field, LP width was determined by 
measuring the width of the vascular region in the center of 
the villus [21,22] and crypt depth was measured as the depth 
of the invaginations located at the base of each villus. 
Leukocytes were identified and counted as described by 
Bjerregaard [23]. 
2.6. Statistical analysis 
All dependent variables were analyzed using a general 
linear model (JMP, SAS, Cary, NC, USA) with analysis of 
variance to determine the main effects of diet, challenge, 
time after the challenge (not included for intestinal histology) 
and their interactions. When interactions were not significant 
(PN.20), they were removed from the model. Tukey's HSD 
(honestly significant difference) was used to assess differ­
ences among all pairwise comparisons. Cage was initially 
included in the statistical analysis, but it was found to be 
nonsignificant in all cases and subsequently dropped from 
the model. Differences were considered significant at Pb.05. Lo-Zn 31.2 194.7 42.4 35.6 9.7 ND 
-4 
Ad-Zn 22.0 6.9 6.1 34.9 15.8 34.7 2.0 C, T 
Lo-Zn 28.2 8.0 2.9 25.5 8.1 ND 
-5 
Ad-Zn 0 18.3 7.5 5.9 13.5 0 1.6 T 
Lo-Zn 0 27.2 12.6 1.2 16.1 ND 
-6 
Ad-Zn 1.5 4865.6 1009.5 2.2 38.7 2.2 320.0 D, C, T, 
Lo-Zn 2.3 4540.6 5066.2 2.1 1.6 ND C�T, D�T 
-10 
Ad-Zn 0 108.8 68.9 0 2.0 9.1 13.6 D, C, T, 3. Results 
Consumption of the Zn-marginal diet for 4 weeks did not 
affect feed intake over the last week of the study, BW change 
over the course of the study, and initial or final BW (Table 1). 
Visual observation revealed that challenge with LPS 
resulted in severe diarrhea 6 and 24 h after the challenge. 
Voluntary locomotor activity was significantly affected by 
the LPS challenge; saline-challenged mice had greater Table 2 
Voluntary locomotor activity of mice 6 or 24 h after challenge by 
intraperitoneal injection of LPS or saline after 4-week treatment with 
either an Ad-Zn or an Lo-Zn diet (n 4 cages/diet, 6 animals/cage for each 
challenge, 12 animals/cage in total) 
Time after 
challenge (h) 
Saline 
Lo-Zn Ad-Zn 
LPS 
Lo-Zn Ad-Zn 
6 
24 
28.3±4.9a 
26.0±6.7a 
21.0±4.5a 
30.5±9.7a 
6.5±2.3b 
3.6±1.3b 
3.5±0.9b 
4.6±2.6b 
Activity was assessed by placing animals in a 78×56-cm cage marked with 
7-cm2 grid lines and by counting the number of squares traversed in 1 min. 
Values are expressed as mean±S.E.M. Differing superscripts within a row 
indicate significant differences (Pb.05). activity than did LPS-challenged animals (26.4 traversed 
squares vs. 4.5 traversed squares, as pooled means for both 
time points and both diet groups, Pb.05; Table 2). 
The immune challenge also affected plasma cytokine 
concentrations (Table 3). Specifically, LPS increased plasma 
IL-6, IL-10, IL-12p40, IFNγ and TNFα (Pb.05 for each) but 
decreased plasma IL-4 and IL-12p70 (Pb.05 for each). The 
Zn-marginal diet led to an overall increase (across all time 
points and for LPS and saline groups combined) in IL-6 
(Pb.05), with a similar trend for IL-10 (P=.07). Of greatest 
interest is the interaction of diet and LPS challenge on 
plasma IL-6 and IL-10 (Pb.05 for each), for which 
concentrations of each cytokine were elevated 6 h after the 
LPS challenge for mice fed with either diet but remained 
elevated 24 h after the injection only for mice fed with the 
Zn-marginal diet (Fig. 1). 
Intestinal histology was affected by diet and the LPS 
challenge. In the jejunum 24 h after the challenge, LPS 
resulted in decreased villus length and increased crypt depth 
(Pb.05 for each; Fig. 2A) as well as increased numbers of 
leukocytes in the intraepithelial and LP regions (Pb.05; Lo-Zn 0 152.4 221.8 0 0 ND C�T, D�T 
-12p40 
Ad-Zn 187.5 481.1 143.7 219.7 250.6 284.5 24.6 T, C�T 
Lo-Zn 271.9 508.5 108.9 227.5 170.6 ND 
-12p70 
Ad-Zn 158.4 29.9 12.1 179.0 96.4 228.7 15.4 C�T 
Lo-Zn 234.5 35.3 16.1 193.5 22.3 ND 
Nγ 
Ad-Zn 458.0 892.1 252.0 577.6 438.7 750.7 73.9 C�T 
Lo-Zn 643.2 1297.9 297.7 530.5 267.2 ND 
NFα 
Ad-Zn 0 175.3 25.5 0.8 0.2 0 14.7 D, C, T 
Lo-Zn 0.4 215.1 127.7 0 0.3 ND 
a Standard error represents the pooled S.E.M. for each cytokine. The 
ffect of diet (D), challenge (C), time (T) or interactions was considered 
gnificant at Pb.05 and is listed in the last column. ND indicates not 
etermined; NS, not significant. T
M
c
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Fig. 2B). Zn status did not significantly affect surface area 
measurements in the jejunum (PN.1 for all; Fig. 3A), but mice 
fed with the Zn-marginal diet had significantly greater 
leukocyte numbers in the intraepithelial region (Pb.05; 
Fig. 3B). Additionally, an interaction between diet and 
challenge demonstrated that mice fed with a Zn-marginal diet 
and challenged with LPS had greater numbers of intraepithe­
lial leukocytes in the jejunum as compared with Zn-adequate 
animals (Diet�Challenge interaction, Pb.05; Fig. 4). 
In the ileum 24 h after the challenge, LPS increased crypt 
depth (Pb.05; Fig. 5A) and led to greater numbers of Fig. 1. IL-6 (A) and IL-10 (B) are induced 6 h after the immune challenge 
and remain elevated at 24 h in Zn-marginal (Lo-Zn) mice but decline in Zn­
adequate (Ad-Zn) mice. Mice were challenged with intraperitoneal 
injection of LPS and then sacrificed 6 and 24 h after the challenge. 
Serum was collected, and serum IL-6 and IL-10 protein concentrations 
were determined. IL-6 values 0 h after the challenge are presented as mean 
(S.E.M.); IL-10 was not detected 0 h after the challenge. Asterisks indicate 
significant difference between the Lo-Zn and Ad-Zn animals (Pb.05); error 
bars represent S.E.M. 
Fig. 2. Effects of immune challenge (white bars indicate saline control; black 
bars, LPS) on intestinal morphology (A) and leukocyte recruitment (B) in 
the jejunum of Ad-Zn and Lo-Zn animals. Significant differences due to the 
challenge are noted by an asterisk (Pb.05); error bars represent S.E.M. leukocytes in the intraepithelial region as well as a 
significant increase in LP leukocyte numbers (Pb.05; 
Fig. 5B). Diet also affected ileum histology; animals fed 
with the Zn-marginal diet had greater villus length and crypt 
depth as compared with the Zn-adequate animals (Pb.05; 
Fig. 6A). Finally, the Zn-marginal diet led to a significantly 
greater number of leukocytes in the LP region as compared 
with animals fed with the Zn-adequate diet (Pb.05; Fig. 6B). 4. Discussion 
This experiment demonstrates that an intraperitoneal LPS 
challenge is sufficient to induce intestinal inflammation. In 
this experiment, immune challenge generally increased crypt 
depth and the number of leukocytes in the jejunum and 
ileum, all of which are responses typical of intestinal 
inflammation. In response to cytokines and other chemical 
mediators induced by an enteric challenge, leukocyte 
infiltration occurs via interaction of leukocyte integrins and 
endothelial cell surface adhesion molecules such as intra­
cellular adhesion molecule [18]. As a result of leukocyte 
infiltration to the intestine, crypt abscess formation may be 
induced, as seen in the current trial in the form of increased 
crypt depth. Additionally, excessive inflammation in the 
intestine may reduce enterocyte barrier function, thus 
allowing additional bacterial and inflammatory challenges 
to occur (reviewed in Reference [24]). 
In addition to intestinal inflammation, systemic inflam­
mation was induced, as evidenced by changes in plasma 
cytokines as well as behavior. In terms of behavioral Fig. 3. Effects of diet (white bars indicate Lo-Zn mice; black bars, Ad-Zn 
mice) on intestinal morphology (A) and leukocyte recruitment (B) in the 
jejunum of LPS-challenged and nonchallenged animals combined. 
Significant differences due to diet are noted by an asterisk (Pb.05); 
error bars represent S.E.M. 
ig. 4. Interaction of immune challenge with LPS or saline (control) and Zn 
atus on leukocyte recruitment in the intraepithelial region of the jejunum. 
ifferent letters indicate significant differences (Pb.05); error bars represent 
.E.M. F
st
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Sresponses, LPS-challenged mice had substantially reduced 
exploratory activity. Previous trials have shown that an LPS 
challenge reduces the frequency of typical behaviors, 
particularly in dominant animals [25], and this response is 
likely due to cytokine action on the brain; LPS has been 
shown to induce TNFα, IFNγ and IL-10 in a similar mouse 
enteric challenge model [26] as well as IL-6, IL-10 and 
TNFα in a cecal ligation model of sepsis [27]. Similarly, the 
LPS challenge in the current trial increased secretion of IL-6, 
IL-10, IFNγ and TNFα. 
Dietary Zn status also affected cytokine secretion and 
intestinal leukocyte numbers. The LPS challenge elicited a 
similar and pronounced immune response in all animals, but 
the response in the Zn-restricted mice was prolonged as 
compared with that in the mice fed with adequate Zn in terms 
of IL-6 and IL-10 and in terms of intestinal leukocyte 
numbers. IL-6 is generally considered to be pro-inflamma­
tory (e.g., [28]), while IL-10 is anti-inflammatory [29] — in 
addition, its levels are generally correlated with those of IL-6 
during bacterial infection [30]. In this trial, inflammatory 
responses appeared to overwhelm anti-inflammatory para­
meters in Zn-restricted mice since enhanced intestinal 
leukocyte infiltration was observed after the LPS challenge 
in these animals. The implications of prolonged inflamma­
tion and leukocyte infiltration in the intestine are 
substantial; resolution of intestinal inflammation is critical 
for host survival due to alterations in intestinal perme­
ability and loss of nutrients and water, increased bacterial 
translocation and other detrimental effects on host 
physiology (reviewed in References [24,31]). It has been 
shown that adequate Zn status prevents barrier disruption 
in the enterocyte monolayer as well as bacterial adhesion 
and internalization [15], which result in intestinal immune 
activation [32]. Further experimentation will be required to 
elucidate the mechanistic basis for the observed interaction 
between diet and LPS challenge on IL-6, IL-10 and 
leukocyte recruitment. 
Fig. 5. Effects of immune challenge (white bars indicate saline control; 
black bars, LPS) on intestinal morphology (A) and leukocyte recruitment 
(B) in the ileum of Ad-Zn and Lo-Zn animals combined. Significant 
differences due to the challenge are noted by an asterisk (Pb.05); error bars 
represent S.E.M. 
ig. 6. Effects of diet (white bars indicate Lo-Zn mice; black bars, Ad-Zn mice) 
n intestinal morphology (A) and leukocyte recruitment (B) in the ileum of 
PS-challenged and nonchallenged animals combined. Significant differences 
ue to diet are noted by an asterisk (Pb.05); error bars represent S.E.M. Interestingly, previous trials have not shown effects of Zn 
status on IL-10, although Zn deficiency has been associated 
with increased production of IL-2 and IFNγ by T helper cells 
[10]. The mechanism by which Zn status may have affected 
IL-10 and IL-6 production in the current trial may be via 
effects on nuclear factor-kappa B (NF-κB) and peroxisome 
proliferator-activated receptor gamma (PPARγ). PPARγ is 
known to suppress expression of inflammatory cytokines 
[33], and Zn deficiency has been shown to reduce PPARγ 
expression and increase NF-κB activation in endothelial 
cells [34]. Regardless of the mechanism, enhancement of IL­
10 is negatively correlated with survival during bacterial 
challenges in humans [30]. 
In contrast to its effects on immune responses, moderate 
Zn restriction in adult mice for 4 weeks had little effect on 
feed intake and BW. Given that mice were at maintenance and that the level of Zn deficiency was moderate — and for a 
relatively short period, this response is not surprising. In 
growing animals, similar levels of dietary Zn have been 
shown to result in reduced growth rate and feed intake due to 
direct effects on appetite-related gene expression in the 
pituitary [35]. The lack of effect on BW and intake in the 
present study despite a 10-fold difference in dietary Zn 
content supports the notion that the Zn deficiency that these 
animals experienced was only moderate. 
In summary, this trial demonstrates that an intraperitoneal 
challenge with LPS is sufficient to induce intestinal 
inflammation and systemic inflammation. Moderate Zn 
restriction in adult mice altered the response to LPS and 
generally resulted in prolonged systemic cytokine levels and 
increased leukocyte infiltration in the small intestine. These 
changes may contribute to the etiology of diarrhea and other F
o
L
d
issues associated with immunocompetence observed in Zn 
deficiency, and this study demonstrates that even moderate 
Zn restriction for a short period may affect immune function. 
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